Compare Stocks: DSRLF, SAUHF, SONVY, and CLPBY

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLPBY Coloplast A/S	$7.28 -1.6%	$6.56	$5.64 ▼ $10.03	$16.68B	0.16	97,418 shs	102,341 shs
DSRLF DiaSorin	$86.00	$81.94	$66.50 ▼ $100.00	$4.71B	0.27	14 shs	N/A
SAUHF Straumann	$118.73	$125.11	$93.18 ▼ $135.00	$18.89B	1.35	1,464 shs	17 shs
SONVY Sonova	$58.55 +0.7%	$54.68	$42.26 ▼ $61.10	$17.33B	1.31	7,483 shs	28,671 shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLPBY Coloplast A/S	-1.62%	+1.68%	+8.33%	+21.33%	-25.41%
DSRLF DiaSorin	0.00%	0.00%	+6.17%	+2.26%	-14.00%
SAUHF Straumann	0.00%	+4.15%	-7.17%	-0.29%	+1.00%
SONVY Sonova	+0.71%	-0.33%	+2.39%	+12.96%	+1.04%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLPBY Coloplast A/S	$7.28 -1.6%	$6.56	$5.64 ▼ $10.03	$16.68B	0.16	97,418 shs	102,341 shs
DSRLF DiaSorin	$86.00	$81.94	$66.50 ▼ $100.00	$4.71B	0.27	14 shs	N/A
SAUHF Straumann	$118.73	$125.11	$93.18 ▼ $135.00	$18.89B	1.35	1,464 shs	17 shs
SONVY Sonova	$58.55 +0.7%	$54.68	$42.26 ▼ $61.10	$17.33B	1.31	7,483 shs	28,671 shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLPBY Coloplast A/S	-1.62%	+1.68%	+8.33%	+21.33%	-25.41%
DSRLF DiaSorin	0.00%	0.00%	+6.17%	+2.26%	-14.00%
SAUHF Straumann	0.00%	+4.15%	-7.17%	-0.29%	+1.00%
SONVY Sonova	+0.71%	-0.33%	+2.39%	+12.96%	+1.04%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CLPBY Coloplast A/S	2.33	Hold	N/A	N/A
DSRLF DiaSorin	1.20	Strong Sell	N/A	N/A
SAUHF Straumann	0.00	N/A	N/A	N/A
SONVY Sonova	2.43	Hold	N/A	N/A

Current Analyst Ratings Breakdown

Latest DSRLF, SAUHF, SONVY, and CLPBY Analyst Ratings

Date	Company	Brokerage	Action	Rating
8/12/2026	DSRLF DiaSorin	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Sell
8/6/2026	DSRLF DiaSorin	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
8/4/2026	DSRLF DiaSorin	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell
7/24/2026	SONVY Sonova	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell
7/22/2026	SONVY Sonova	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Buy
7/7/2026	DSRLF DiaSorin	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Neutral ➝ Underperform
6/23/2026	SONVY Sonova	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Underweight ➝ Equal Weight
6/17/2026	DSRLF DiaSorin	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Sell
6/11/2026	DSRLF DiaSorin	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral

(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CLPBY Coloplast A/S	$4.13B	3.97	$0.35 per share	20.64	$1.06 per share	6.87
DSRLF DiaSorin	$1.28B	3.67	N/A	N/A	N/A	∞
SAUHF Straumann	$2.43B	7.77	$2.87 per share	41.32	N/A	∞
SONVY Sonova	$4.50B	3.88	$3.81 per share	15.36	$11.03 per share	5.31

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CLPBY Coloplast A/S	$538.49M	$0.19	38.32	17.33	2.79	9.68%	38.81%	11.52%	11/3/2026 (Estimated)
DSRLF DiaSorin	$203.55M	N/A	N/A	17.52	N/A	N/A	N/A	N/A	11/5/2026 (Estimated)
SAUHF Straumann	$455.89M	N/A	N/A	31.41	N/A	N/A	N/A	N/A	10/28/2026 (Estimated)
SONVY Sonova	$536.96M	N/A	N/A	18.47	4.29	N/A	N/A	N/A	11/12/2026 (Estimated)

Latest DSRLF, SAUHF, SONVY, and CLPBY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/18/2026	Q3 2026	CLPBY Coloplast A/S	$0.10	$0.10	N/A	$0.10	$1.11 billion	$1.14 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CLPBY Coloplast A/S	$0.08	1.10%	N/A	42.11%	N/A
DSRLF DiaSorin	N/A	N/A	N/A	N/A	N/A
SAUHF Straumann	N/A	N/A	N/A	N/A	N/A
SONVY Sonova	$0.68	1.16%	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CLPBY Coloplast A/S	1.66	1.75	1.09
DSRLF DiaSorin	N/A	N/A	N/A
SAUHF Straumann	N/A	N/A	N/A
SONVY Sonova	0.51	1.75	1.43

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CLPBY Coloplast A/S	N/A
DSRLF DiaSorin	N/A
SAUHF Straumann	N/A
SONVY Sonova	0.01%

Insider Ownership

Company	Insider Ownership
CLPBY Coloplast A/S	N/A
DSRLF DiaSorin	N/A
SAUHF Straumann	N/A
SONVY Sonova	0.01%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CLPBY Coloplast A/S	17,156	2.25 billion	N/A	Not Optionable
DSRLF DiaSorin	3,249	54.71 million	N/A	Not Optionable
SAUHF Straumann	10,500	159.10 million	N/A	Not Optionable
SONVY Sonova	18,447	298.04 million	298.01 million	Not Optionable

DSRLF, SAUHF, SONVY, and CLPBY Headlines

Recent News About These Companies

Sonova unveils new AI-powered hearing-aid platform to support growth targets

August 24, 2026 | reuters.com

IART vs. SONVY: Which Stock Is the Better Value Option?

July 22, 2026 | zacks.com

IART or SONVY: Which Is the Better Value Stock Right Now?

July 6, 2026 | zacks.com

IART vs. SONVY: Which Stock Is the Better Value Option?

June 19, 2026 | zacks.com

Sonova Earnings Call Highlights Growth, Margins And Risks

June 16, 2026 | tipranks.com

Sonova investors back record dividend and board slate at 41st AGM

June 16, 2026 | tipranks.com

GMED vs. SONVY: Which Stock Is the Better Value Option?

May 20, 2026 | zacks.com

Sonova Holding AG (SONVY) Q4 2026 Earnings Call Transcript

May 18, 2026 | seekingalpha.com

Sonova FY 2025-26 profit beats estimates despite China headwinds

May 18, 2026 | au.investing.com

Sonova Beats Profit Forecasts Despite Cochlear Implant Weakness

May 18, 2026 | econotimes.com

Sonova lifts profitability, beats market with AI hearing solutions and record dividend

May 18, 2026 | tipranks.com

Sonova Holding AG (SOON) Gets a Hold from Goldman Sachs

April 15, 2026 | theglobeandmail.com

Sonova sets up APAC hub and innovation center in Singapore to drive regional growth

March 31, 2026 | tipranks.com

Sonova Holding AG (SONVY) Discusses Refreshed Strategy and Vision for Next Phase of Growth Transcript

March 24, 2026 | seekingalpha.com

SONVY vs. IDXX: Which Stock Should Value Investors Buy Now?

March 9, 2026 | zacks.com

SONVY or IDXX: Which Is the Better Value Stock Right Now?

February 20, 2026 | zacks.com

Sonova expects FY revenue at lower end of target range, CEO says in interview

February 20, 2026 | reuters.com

Sonova Holding AG - Depositary receipt (SONVY) price target decreased by 39.37% to 69.59

February 4, 2026 | msn.com

HOLX vs. SONVY: Which Stock Should Value Investors Buy Now?

January 8, 2026 | zacks.com

HOLX or SONVY: Which Is the Better Value Stock Right Now?

January 7, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

DSRLF, SAUHF, SONVY, and CLPBY Company Descriptions

Coloplast A/S OTCMKTS:CLPBY

$7.28 -0.12 (-1.62%)

As of 09/3/2026 03:58 PM Eastern

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

DiaSorin OTCMKTS:DSRLF

$86.00 0.00 (0.00%)

As of 09/2/2026

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Straumann OTCMKTS:SAUHF

$118.73 0.00 (0.00%)

As of 09/2/2026 09:47 AM Eastern

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners. In addition, it offers resins for 3D printing and thermoplastics for clear aligner production; and biomaterials for tissue generation. Further, it provides digital equipment comprising scanners, milling machines and 3D printers. Further, it offers training and education services. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

Sonova OTCMKTS:SONVY

$58.55 +0.42 (+0.71%)

As of 09/3/2026 03:50 PM Eastern

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest DSRLF, SAUHF, SONVY, and CLPBY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest DSRLF, SAUHF, SONVY, and CLPBY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

DSRLF, SAUHF, SONVY, and CLPBY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

DSRLF, SAUHF, SONVY, and CLPBY Company Descriptions

Coloplast A/S OTCMKTS:CLPBY

DiaSorin OTCMKTS:DSRLF

Straumann OTCMKTS:SAUHF

Sonova OTCMKTS:SONVY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest DSRLF, SAUHF, SONVY, and CLPBY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest DSRLF, SAUHF, SONVY, and CLPBY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

DSRLF, SAUHF, SONVY, and CLPBY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

DSRLF, SAUHF, SONVY, and CLPBY Company Descriptions

Coloplast A/S OTCMKTS:CLPBY

DiaSorin OTCMKTS:DSRLF

Straumann OTCMKTS:SAUHF

Sonova OTCMKTS:SONVY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools